Form 8-K - Current report:
SEC Accession No. 0001641172-25-005263
Filing Date
2025-04-17
Accepted
2025-04-17 17:00:26
Documents
15
Period of Report
2025-04-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 47891
2 ex10-1.htm EX-10.1 228237
3 ex10-2.htm EX-10.2 90903
  Complete submission text file 0001641172-25-005263.txt   616445

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE mgrx-20250411.xsd EX-101.SCH 3033
5 XBRL LABEL FILE mgrx-20250411_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE mgrx-20250411_pre.xml EX-101.PRE 22371
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3800
Mailing Address 15110 DALLAS PKWY, SUITE 600 DALLAS TX 75248
Business Address 15110 DALLAS PKWY, SUITE 600 DALLAS TX 75248 (833) 626-4679
MANGOCEUTICALS, INC. (Filer) CIK: 0001938046 (see all company filings)

EIN.: 873841292 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41615 | Film No.: 25848133
SIC: 8090 Services-Misc Health & Allied Services, NEC
(CF Office: 03 Life Sciences)